Tradestie Institutional Equity Comparison Engine

IPOD vs ABSI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IPOD Overall Edge

IPOD Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to IPOD (IPOD) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABSI counters with relative strength in Options & Structure. Fundamentally, IPOD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABSI at N/M Forward P/E and -9108.3% operating margin (-19.6% YoY). In options structure, IPOD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABSI sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IPOD
IPOD N/M vs ABSI N/M Fwd P/E
Growth & Margin Winner IPOD
Op Margin 0.0% vs -9108.3% ยท YoY +0.0% vs -19.6%
Momentum & Technical Winner IPOD
1Y +3.8% vs +183.1% ยท 52W Pos 100% vs 51%
Options & Structure Winner ABSI
UNCLASSIFIED (N/A IV) vs BREAKDOWN (15th %ile IV)
IPOD US Equity
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap $210.0M
1M Return +0.97%
1Y Return +3.84%
Forward P/E N/M
Unified AI Score
58.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.47
-11.54% 1D
Market Cap $1.5B
1M Return -9.39%
1Y Return +183.14%
Forward P/E N/M
Unified AI Score
41.3 / 100 SELL
Tech 30.0 Fund 52.0 Flow 71.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IPOD +3.84% ABSI +183.14% Spread: +85.47 pp (ABSI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IPOD TTM Op. Margin: 0.0% ABSI TTM Op. Margin: -9108.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPOD vs ABSI. Trailing 12-month operating profitability (IPOD 0.0% vs ABSI -9108.3%) and valuation multiples (IPOD N/M vs ABSI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IPOD (7) vs ABSI (1)
Institutional Metric IPOD ABSI Criterion Row Winner
Market Capitalization Scale $210.0M $1.5B Larger Scale ABSI
Trailing P/E Ratio Valuation 39.9x N/M Lower Multiple IPOD
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -19.6% Higher Growth IPOD
Operating Margin (TTM) Profitability 0.0% -9108.3% Higher Margin IPOD
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 0.0% -58.6% Higher ROE IPOD
52-Week Range Position Momentum 100% ($10โ€“$10) 51% ($2โ€“$13) Stronger Trend IPOD
Beta / 30D Volatility Risk Regime 0.00ฮฒ ยท 2% Vol 3.34ฮฒ ยท 128% Vol Lower Realized Risk IPOD
Unified Institutional Score Composite Signal 58.0 / 100 (HOLD) 41.3 / 100 (SELL) Higher Composite IPOD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IPOD vs ABSI Buy Guide
IPOD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IPOD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABSI BREAKDOWN
97d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live ABSI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IPOD nor ABSI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.